Newsfeed

Newsfeed


On #WorldCancerResearchDay we shine a light on our collaborators in Australia & around the world who work tirelessly on our uveal / ocular melanoma research. It’s thanks to their dedication & innovation that outcomes continue to improve for uveal melanoma patients.
@MASC_Trials https://t.co/bckQN4uMOe
AOMA_MASC photo

The September edition of the MASC Trials eNews is out now! Read about:
✅ New trial for melanoma that has spread to the brain
✅ Annual Scientific Meeting to be held in March '23
✅ IMAGE trial participant, Viv Chapman
✅ First major fundraising campaign

https://t.co/8Dnvg2Xlrr https://t.co/xq4XwbI26h
AOMA_MASC photo

Our former CEO Aileen Boyd-Squires has committed to hiking 55km in December to raise money for Melanoma and Skin Cancer Trials. Help Aileen reach her fundraising goal of $1000 by clicking this link and donating today: https://t.co/joQtC5JoX4

AOMA Chair @AnthonyMJoshua is leading a new #UvealMelanoma trial, in collaboration with @MASC_Trials Chair Mark Shackleton. The #NADOM trial will evaluate Darovasertib in neo-adjuvant and adjuvant settings for non-metastatic uveal melanoma patients. Read: https://t.co/1oV8sJy7XC

Save the Date - MASC Trials Annual Scientific Meeting!
Time: 2pm–5pm
Date: Thurs, 23 March 2023
Venue: Brisbane Convention & Exhibition Centre
The MASC Trials ASM will precede the Australasian Melanoma Conference, also at BCEC, and is open to healthcare professionals & consumers. https://t.co/Fu95jf1BPR
AOMA_MASC photo

How often do you consult Dr Google? Not all melanoma and skin cancer online info is evidence-based & it can be hard to tell fact from fiction. With @melanomasupport we created a Skin Cancer Health Information Guide for consumers. Download: https://t.co/JQljn19ud9
@DrVictoriaMar https://t.co/6Uu2BPFzRC
AOMA_MASC photo

Research

Communications

Support

Melanoma and Skin Cancer Trials Logo
Australasian Merkel Cell Carcinoma Interest Group logo